EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

If the effects of the methods are durable, perhaps they can be applied to all cases of lupus. The new study points to the possibility of improved treatments for lupus in the future. The ...

Patients living with a debilitating immune system disorder that can lead to skin rashes, joint pain and even death are set to receive ground-breaking new treatment. The condition, lupus ...

In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

Systemic lupus erythematosus is associated with substantial ... more targeted therapeutic interventions and the development of new biological drugs. [2] In this paper, we review the findings ...

The event raised awareness for those with lupus, a chronic autoimmune disease that leads the body’s immune system to attack ...

Neutropenia, a condition characterized by low neutrophil levels, is common in individuals with systemic lupus erythematosus (SLE) and can lead to severe infections. A new study investigates the role ...

More than 100 autoantibodies have been identified in lupus, opening up promising new R&D pathways to potentially deliver precision therapeutics. 11 Biogen is working to deliver the industry’s ...